toosendanin has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QL; Chen, XP; Dong, Y; Fu, J; Keon, KA; Li, M; Lu, JH; Lu, JJ; Rubinstein, JL; Shen, HM; Wang, SF; Zeng, SX; Zhang, S; Zhu, G | 1 |
| Li, J; Liang, ZX; Ma, Y; Mei, C; Wang, HJ; Xian, H; Yang, Y; Zhang, X; Zhi, Y | 1 |
| Ao, H; Cai, J; Chen, Y; Hu, M; Huang, R; Xu, M; Ye, Q; Ye, Z; Zhang, C; Zhang, M; Zhu, S | 1 |
| Cao, L; Li, Z; Ma, J; Wang, ZR; Zhang, S | 1 |
2 review(s) available for toosendanin and Benign Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate.
Topics: Animals; Ascaris; China; Drugs, Chinese Herbal; Humans; Neoplasms | 2023 |
Anti-cancer effect of toosendanin and its underlying mechanisms.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Drugs, Chinese Herbal; Molecular Structure; Neoplasms | 2019 |
2 other study(ies) available for toosendanin and Benign Neoplasms
| Article | Year |
|---|---|
Toosendanin, a novel potent vacuolar-type H
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Autophagy; Chromatography, Liquid; Humans; Neoplasms; Rats; Tandem Mass Spectrometry; Triterpenes; Vacuolar Proton-Translocating ATPases | 2022 |
Toosendanin-induced apoptosis of CMT-U27 is mediated through the mitochondrial apoptotic pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cytochromes c; Dog Diseases; Dogs; Drugs, Chinese Herbal; Humans; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Rodent Diseases; Tumor Suppressor Protein p53 | 2023 |